Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedLocations section added with Michigan and New York. Separate Michigan Locations and New York Locations subsections were removed, and the HHS Vulnerability Disclosure footer link was removed.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe only change is a site revision update (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe notice about government funding and potential operating delays has been removed; this does not affect the core trial information such as eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedThe update shows only minor UI refinements with no changes to core study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check88 days agoChange DetectedUpdated operating status notice and added version 3.2.0; removed the GI stromal tumor resource (from the Genetic and Rare Diseases Information Center) and the prior version tag v3.1.0.SummaryDifference3%

- Check95 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.